Who Paid My Doc
Epkinly
Drug Oncology
NDC 82705-010-01
General payments
$5,198,987
Research payments
$66,810,735
Through program year 2025, $5,198,987 in general payments and $66,810,735 in research payments were reported against Epkinly (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $2,039,893 | 21,229 |
| 2025 | Research | $33,514,652 | 4,598 |
| 2024 | General | $2,028,378 | 19,172 |
| 2024 | Research | $18,064,479 | 2,628 |
| 2023 | General | $1,130,717 | 8,294 |
| 2023 | Research | $15,231,604 | 1,293 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 103 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 54 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
48,695 general · 8,519 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.